IMMUNOVACCINE TECHNOLOGIES INC.

10 records totalling $5,661,363.01 CAD, from official Government of Canada open data.

Embed this chart

By department

National Research Council Canada $5,661,363 10 records

Records

ImmunoVaccine Technologies Inc. $2,655,429.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2020-2021
Canada

In response to the global crisis, IMV has initiated the development of a vaccine to protect against the COVID-19 pandemic. We believe our targeted peptide epitope approach has the potential to optimiz...

ImmunoVaccine Technologies Inc. $640,332.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
FY 2020-2021
Canada

The funding provided from the IAP program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

ImmunoVaccine Technologies Inc. $636,596.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2020-2021
Canada

This project aims to establish the clinical safety and immunogenicity of a vaccine candidate based on the Company’s DPX delivery technology and incorporating peptides targeting novel epitopes from the...

ImmunoVaccine Technologies Inc. $25,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2020-2021
Canada

This project will provide cyber security assistance to a priority covid response firm.